Ethan Ludmir MD
@ebludmir
Radiation oncology & biostatistics, MD Anderson Cancer Center. Views my own.
ID: 840216262575816704
10-03-2017 15:02:22
739 Tweet
1,1K Takipçi
1,1K Takip Edilen
Wonderful to see in person the impact on clinical outcomes given by SBRT added on top of standard of care management across all subgroups of oligometastatic prostate cancer!,Chad Tang, MD ,#GU25
Starting the day ✨inspired✨ 🤩 Thrilled to host Peter WT Pisters, MD in a special session for the MD Anderson Cancer Center #RadOnc #residents #fellows #physicsresidents ☢️ Thank you, Dr. Pisters!! Albert Koong, MD PhD Chelsea C Pinnix MD PhD Prajnan Das, MD, MS, MPH Emma B. Holliday MD
Great experience working with this group of oncologists around the world to assemble this manuscript on the roles of RT for HCC! Led by rising stars: Ethan Ludmir MD Stephanie Dudzinski MD, PhD thelancet.com/journals/langa…
With emerging evidence, #HCC therapeutic guidelines should include the growing role of external-beam RT in improving the quality of life for patients with #LiverCancer. This The Lancet Gastroenterology & Hepatology paper was led by Stephanie Dudzinski MD, PhD, Ethan Ludmir MD, and co-authors. bit.ly/4bigjRW
Our critical review of contemporary radiation therapy for locally advanced #pancreaticcancer is in press IJROBP - The Red Journal 🙌 Jonathan Ashman, MD Krishan Jethwa Jordan Kharofa Eugene J. Koay, MD, PhD Ethan Ludmir MD Eric Miller Marsha Reyngold Dr. Nina Niu Sanford Daniel Chang redjournal.org/article/S0360-…
It's finally official! Radiosa joined the X-MET study by Chad Tang, MD ! I like to think about Radiosa as Rogue 😜#wolverinestudy #oligometastaticPCa #radoncGU #radiosatrial
Haha, welcome to the team! We are gonna do great stuff together Ethan Ludmir MD Albert Koong, MD PhD
Less than half of phase 3 #clinicaltrials reported toxicity in a guideline-concordant manner. Nearly half of trials used what researchers characterized as toxicity-minimizing language. Healio spoke with Ethan Ludmir MD of MD Anderson Cancer Center about the data 👇 bit.ly/3QZoj0Z
Terrific work by Alexander Sherry and wonderful colleagues including CSO friends, w simultaneous pub in JAMA Oncology jamanetwork.com/journals/jamao… Pavlos Msaouel Fumiko Ladd Chino, MD, FASCO Dr. Nina Niu Sanford Bishal Gyawali, MD, PhD, FASCO Joseph Abi Jaoude Ramez Kouzy, MD
Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4dVJAU8
Congrats to the MD Anderson Cancer Center radiation oncology class of 2025. Honored to get the James Cox mentoring award. Thanks Alexander Sherry and Aaron Seo for being amazing mentees.
Coming out party / preprint for Vince Bernard-Pagan, MD PHD who starts his faculty position MD Anderson Cancer Center in a week. This study identifies adaptive responses to radiation therapy in pancreatic cancer using single cell & spatial profiling, resulting in persister cell populations post XRT.
Thrilled to announce that after a highly competitive national search, Prajnan Das, MD, MS, MPH has been selected as the inaugural chair of GIRO Department MD Anderson Cancer Center. Looking forward to all the great things he will do in this new role. #rad onc #endcancer
#TumorBoardTuesday 😮We had a rare #ASCO25 with several key🗝️updates in #PancreaticCancer So to put this in context: 📢Join us Tuesday, 07-08-25 at 8PM ET as Dr. Shubham Pant & Daniel Haldar 🗣️Optimizing 1L Treatment Selection in mPDAC RT and bring others into the discussion‼️
Yup what a ride. Still got a some more to go. Appreciate our study team, our awesome med oncs who support the trial Pavlos Msaouel Andy Hahn Omar Alhalabi, MD (many more not on X), and of course our patients.
While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4m3Eesv Alexander Sherry Bishal Gyawali, MD, PhD, FASCO Pavlos Msaouel Ethan Ludmir MD
